George Whitesides sold Theravance Biopharma Inc (NASDAQ: TBPH)
George Whitesides (D-CA), a U.S. Representative, has disclosed 1 trade in Theravance Biopharma Inc (TBPH) since 2025, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: George Whitesides sold $15,001 - $50,000 of Theravance Biopharma Inc (NASDAQ: TBPH) on March 24, 2025. Since that trade, TBPH is up +79.45% against the S&P 500 up +30.68%, an outperformance of +48.77%.
Data updated
George Whitesides's TBPH trades vs the price
TBPH is up +79.45% since George Whitesides sold on March 24, 2025, versus +30.68% for the S&P 500.
Performance since this trade
All George Whitesides TBPH trades
George Whitesides & TBPH trading FAQ
Is it legal for George Whitesides to trade Theravance Biopharma Inc (TBPH) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Theravance Biopharma Inc (TBPH), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did George Whitesides sell TBPH?
George Whitesides disclosed a sale of $15,001 - $50,000 of Theravance Biopharma Inc (TBPH) on March 24, 2025, according to public STOCK Act filings.
How has TBPH performed since George Whitesides's trade?
Since George Whitesides sold TBPH on March 24, 2025, the stock is up +79.45%, versus +30.68% for the S&P 500 over the same period, an outperformance of +48.77%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional TBPH trades?
Quantellect tracks every disclosed congressional trade in Theravance Biopharma Inc (TBPH) on the Theravance Biopharma Inc congressional trading page, which aggregates filings across all members of Congress.
George Whitesides's TBPH tradesAll congressional filings for Theravance Biopharma IncGeorge Whitesides's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.